Skip to main content
. 2023 May 2;17:11782234231167655. doi: 10.1177/11782234231167655

Table 2.

Predictive power of molecular and pathological factors for pCR.

Variable Pathological response
P Odds ratio (95% CI) PPV (%) NPV (%) Sensitivity (%) Specificity (%)
pCR (n = 57)
RD (n = 263)
n % n %
TP53 signature
 Wild-type signature (n = 171) 5 2.9 166 97.1 <.0001 1 34.9 97.1 91.2 63.1
 Mutant signature (n = 149) 52 34.9 97 65.1 17.8 (6.8-46.1)
Grade
 1-2 (n = 150) 8 5.3 142 94.7 <.0001 1 30.5 94.7 85.5 57.0
 3 (n = 154) 47 30.5 107 69.5 7.8 (3.5-17.2)
Intrinsic subtype
 Luminal A (n = 114) 3 2.6 111 97.4 <.0001 1 26.2 97.4 94.7 42.2
 The others (n = 206) 54 26.2 152 73.8 13.1 (4.0-43.1)
ER
 Positive (n = 198) 19 9.6 179 90.4 <.0001 1 31.9 90.4 66.7 68.8
 Negative (n = 119) 38 31.9 81 68.1 4.4 (2.4-8.1)
PR
 Positive (n = 176) 19 10.8 157 89.2 .0002 1 27.1 89.2 66.7 60.6
 Negative (n = 140) 38 27.1 102 72.9 3.1 (1.7-5.6)

Abbreviations: CI, confidence interval; ER, estrogen receptor; NPV, negative predictive value; pCR, pathological complete response; PPV, positive predictive value; RD, residual disease.